Protect Roe v. Wade and defend access to abortion and reproductive health care.

Chellie Pingree · Maine · Democratic

policy impact 0.95 specificity 0.88 extraction confidence 99%

Contest this claim

Occurrences

Chellie is committed to protecting Roe v. Wade, an essential piece of Supreme Court precedent that has ensured access to safe abortions for more than forty years.

Commits to protecting abortion rights and related care access.

Issues - Chellie Pingree for Congress : Chellie Pingree for Congress
campaign · campaign_site · model gpt-5.4-mini

She's also fighting every attempt to roll back access to basic care, including making sure that women don’t have to pay out-of-pocket for birth control, preserving programs that help low-income Mainers afford preventive care like STD and cancer screenings, and resisting efforts defund Planned Parenthood.

Commits to protecting contraception coverage, preventive care, and Planned Parenthood funding.

Issues - Chellie Pingree for Congress : Chellie Pingree for Congress
campaign · campaign_site · model gpt-5.4-mini

Evidence

On the campaign site, Pingree says she is committed to protecting Roe v. Wade and fighting efforts to roll back access to abortion and basic care.

This is the clearest campaign-era statement of the promise itself.

never same_term

Issues - Chellie Pingree for Congress : Chellie Pingree for Congress
campaign · model gpt-5.4-mini · confidence 93%

Contest this evidence item

The House passed the rule for consideration of H.R. 3755, the Women's Health Protection Act, 217-207; Pingree voted Yea.

Pingree supported advancing the House floor process for the bill meant to protect abortion access nationwide.

partial same_term A for effort

Office of the Clerk, U.S. House of Representatives: Roll Call 264
secondary · model gpt-5.4-mini · confidence 98%

Contest this evidence item

On passage of H.R. 3755, the Women's Health Protection Act, Pingree voted Nay?

This record shows Pingree's vote on final passage of the House WHPA bill; the bill passed the House but did not become law.

partial same_term A for effort

Office of the Clerk, U.S. House of Representatives: Roll Call 294
secondary · model gpt-5.4-mini · confidence 71%

Contest this evidence item

The Senate cloture vote on the motion to proceed to WHPA was not invoked, 49-51, leaving the bill blocked in the Senate.

The companion Senate effort failed, so the Roe-codifying legislation Pingree supported did not become law.

never same_term A for effort

S.4132 - Women's Health Protection Act of 2022
secondary · model gpt-5.4-mini · confidence 98%

Contest this evidence item

Pingree and 240 Members of Congress submitted an amicus brief supporting FDA-approved mifepristone access after the Kacsmaryk ruling.

She took an affirmative public action to defend abortion medication access after Roe was overturned.

partial same_term A for effort

Pingree Joins Amicus Brief Urging Appeals Court to Maintain Access to Mifepristone
secondary · model gpt-5.4-mini · confidence 96%

Contest this evidence item

Her office said she supported ending Hyde, boosting Title X, and protecting medication abortion in the FY2023 appropriations bill.

This shows ongoing legislative efforts to defend reproductive health care after Roe was overturned.

partial same_term A for effort

AFTER ROE: In Appropriations Committee, Pingree Fights to Expand Abortion Access
secondary · model gpt-5.4-mini · confidence 95%

Contest this evidence item

Assessments

never same_term A for effort

The promised outcome was to protect Roe v. Wade and defend abortion/reproductive health access. Roe was overturned, and the major federal legislative vehicle to codify abortion protections, the Women's Health Protection Act, did not become law after Senate failure. Pingree took serious affirmative actions, including supporting House action on WHPA, appropriations efforts, and an amicus brief defending mifepristone access, but those efforts did not deliver the promised nationwide protection or restore Roe-level access.

provider codex_cli · model gpt-5.5 · confidence 92%